DXR

Daxor Corporation is a medical instrumentation and biotechnology company that develops and markets diagnostic products to improve patient outcomes in cardiovascular diseases. The company's primary product is the BVA-100 Blood Volume Analyzer, which uses nuclear medicine technology to provide precise measurements of a patient's blood volume. This information helps physicians optimize treatment decisions for patients with heart failure, hypertension, and other cardiovascular conditions. Daxor's blood volume analysis technology can reduce hospital readmissions and improve medication management by providing objective data on a patient's fluid status. The company has received FDA clearance for its technology and is working to expand adoption in hospitals and medical centers.